Alvotech And Jamp Launch First Stelara Biosimilar In Canada
Jamteki Version Of Ustekinumab Introduced By Jamp Is Country’s First Stelara Rival
Alvotech and Jamp have launched Canada’s first Stelara biosimilar, just a couple of weeks after Alvotech disclosed a settlement that would allow its ustekinumab product to be introduced in markets around the world.
